Literature DB >> 12122726

Epidemiology of inflammatory bowel disease.

Edward V Loftus1, William J Sandborn.   

Abstract

The incidence of IBD has either continued to increase or has stabilized at a high rate in most developed countries, whereas the incidence continues to rise in regions where IBD had been less common. The prevalence has continued to increase as a result of a combination of previously rising incidence and improved survival. Regardless of the exact prevalence, the burden of disease in North America and Europe is significant. Studying the patterns of geographic variation and age and gender distribution may yield important clues to the cause of IBD.

Entities:  

Mesh:

Year:  2002        PMID: 12122726     DOI: 10.1016/s0889-8553(01)00002-4

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  126 in total

1.  Rates of self-reported urinary, gastrointestinal, and pain comorbidities in women with vulvar lichen sclerosus.

Authors:  Mitchell B Berger; Nicholas J Damico; Stacy B Menees; Dee E Fenner; Hope K Haefner
Journal:  J Low Genit Tract Dis       Date:  2012-07       Impact factor: 1.925

2.  The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.

Authors:  Carol J Díaz-Díaz; Sean M Ronnekleiv-Kelly; Manabu Nukaya; Peter G Geiger; Silvia Balbo; Romel Dator; Bryant W Megna; Patrick R Carney; Christopher A Bradfield; Gregory D Kennedy
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

3.  Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients.

Authors:  Min Lü; Bing Xia; Liuqing Ge; Yi Li; Jie Zhao; Fan Chen; Feng Zhou; Xiaolian Zhang; Jinquan Tan
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

4.  Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients.

Authors:  Rupert W L Leong; Ian C Lawrance; Jessica Y L Ching; Carrian M Y Cheung; Sara S L Fung; Jenny N C Ho; Jillian Philpott; Alison R Wallace; Joseph J Y Sung
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

5.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

6.  Evidence against a systemic arterial defect in patients with inflammatory bowel disease.

Authors:  Luke A Neill; Christine M Saundry; Neil H Hyman; George C Wellman
Journal:  J Surg Res       Date:  2014-04-16       Impact factor: 2.192

Review 7.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

8.  Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-κB/nitric oxide pathway and inhibition of cytokine production: A hypothesis.

Authors:  Hamid Reza Rahimi; Mahdi Shiri; Ali Razmi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-12-06

Review 9.  Inflammatory bowel disease.

Authors:  Daniele Corridoni; Kristen O Arseneau; Fabio Cominelli
Journal:  Immunol Lett       Date:  2014-06-02       Impact factor: 3.685

10.  Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.

Authors:  Toufic A Kabbani; Ioannis E Koutroubakis; Robert E Schoen; Claudia Ramos-Rivers; Nilesh Shah; Jason Swoger; Miguel Regueiro; Arthur Barrie; Marc Schwartz; Jana G Hashash; Leonard Baidoo; Michael A Dunn; David G Binion
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.